NOT FOR REPRINT
Page Printed from: benefitspro.com/author/profile/sarah-varney-kaiser-health-news
Sign In To follow
The reluctance of drugmakers to pause operations in Russia is being met with a growing chorus of criticism.
As major pharmaceutical companies look to capitalize on the opportunity, the playbook unfolding in India seems eerily familiar.